Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
75,955
+18,351
+32% +$284K 0.02% 570
2026
Q1
$778K Buy
57,604
+6,545
+13% +$91.6K 0.02% 614
2025
Q4
$636K Buy
51,059
+19,819
+63% +$214K 0.01% 740
2025
Q3
$333K Buy
+31,240
New +$304K 0.01% 915
2025
Q1
$466K Sell
53,454
-41,303
-44% -$434K 0.01% 746
2024
Q4
$1.18M Buy
94,757
+4,562
+5% +$56.1K 0.04% 380
2024
Q3
$1.05M Sell
90,195
-3,070
-3% -$35.4K 0.04% 384
2024
Q2
$991K Buy
+93,265
New +$1.03M 0.04% 372

Other funds holding VTRS

Caprock Group's VTRS Position: Q2 2026 in Review

Caprock Group increased its Viatris (VTRS) stake by 32% in Q2 2026, buying an estimated $284K and bringing the position to 75,955 shares worth $1.21M. The position accounts for 0.02% of the portfolio, ranked #570.

Caprock Group first reported a position in VTRS in Q2 2024 and has held it in 8 quarters since. 1,024 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Caprock Group held 75,955 shares of Viatris worth $1.21M as of Q2 2026.
  • Caprock Group bought 18,351 Viatris shares in Q2 2026, an estimated $284K.
  • Viatris made up 0.02% of Caprock Group's portfolio in Q2 2026, its #570 holding.
  • Caprock Group first reported a position in Viatris in Q2 2024 and has held it in 8 quarters since.
  • 1,024 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.